View Press Releases
RxTE Health Appoints Senior Vice President of Clinical Operations
SILICON VALLEY, CA, UNITED STATES - Nov 28, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that it has expanded its executive team with the addition of Sara Linnerooth, PharmD, as Senior Vice President of Clinical Operations. In this role, Linnerooth will be responsible for the overall strategy and execution of clinical development activities, including solution design and driving the product roadmap for RxTE.
Linnerooth brings extensive clinical and pharmacy experience to her new role at RxTE. Most recently, Linnerooth worked as a clinical pharmacist for WellDyneRx, a leading prescription benefit manager (PBM). During her two years at the full-service PBM, Linnerooth was responsible for developing clinical programs and utilization management strategies, as well as managing formularies. Linnerooth received her Doctorate of Pharmacy from Regis University in Denver, Colo. in 2014.
As we continue to collaborate with a growing number of employers and PBMs to bring down pharmacy costs, it is very exciting to bring Sara onboard to ensure we continue to deliver clinically backed and proven pharmacy benefit solutions, said David Henka, President and CEO of RxTE. We are thrilled to leverage Saras clinical expertise in order to provide our clients with tools that drive significant cost savings.
RxTE works with employers across the country to implement reference pricing, an innovative payment model proven to significantly move the needle on healthcares fastest growing (and third largest) cost driver: pharmaceuticals. Using a propriety algorithm, RxTE leverages insurer/employer contributions and economic incentives to encourage patients to select less expensive drugs that are biologically equivalent to their name-brand counterparts. RxTEs solution drives average savings of 20 percent per year on pharmacy plans.
In recent years, we have seen more and more people not adhering to treatment plans only because they cant afford the medication prescribed by their doctors, which not only results in poor outcomes, but drives up healthcare costs, said Linnerooth. I am excited to join a company that is actively and successfully helping to curb growing pharma costs. More than that, I am honored to join a company that is giving people the tools they need to be more empowered and engaged with their healthcare and make more informed decisions about their prescription drugs.
About RxTE Health
Since 2010, RxTE Health (RxTE) has worked with some of the countrys largest employers across multiple industries, including unions and trusts, to effectively drive down pharmacy costs. RxTE leverages a reference pricing model which applies a proprietary algorithm scientifically proven to drive immediate and ongoing savings of more than 20 percent, while also empowering members and their doctors to select the most cost-effective drug treatment. To start lowering costs, increase benefit plan adherence and improve the well-being of employees, visit www.rxtehealth.com.
Aria Marketing for RxTE Health
(617) 332-9999 x 216